NON-FINAL ACTION - MAILED
final action
on 02 Jan 2025
Last Applicant/ Owned by
55 CAMBRIDGE PARKWAY, SUITE 800E
CAMBRIDGE
MA
02142
Serial Number
98638645 filed on 09th Jul 2024
Registration Number
N/A
Correspondent Address
Christina M. Licursi
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
SERIF
Drug development services, namely, pharmaceutical drug development services; scientific research, namely, research and analysis services for the design and characterization of biologic therapeutic products, namely, pharmaceutical drug development services; pharmaceutical and biotech research and development, namely, pharmaceutical drug development services Biological and chemical agents for scien Read More
Classification Information
Class [042]
Computer & Software Services & Scientific Services
Drug development services, namely, pharmaceutical drug development services; scientific research, namely, research and analysis services for the design and characterization of biologic therapeutic products, namely, pharmaceutical drug development services; pharmaceutical and biotech research and development, namely, pharmaceutical drug development services
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [005]
Pharmaceutical Products
Pharmaceutical preparations for the treatment and prevention of cancer, cardiovascular diseases and disorders, respiratory diseases and disorders, gastrointestinal diseases and disorders, genetic and genomic diseases and disorders, immunological diseases and disorders, metabolic diseases and disorders, endocrine diseases and disorders, kidney diseases and disorders, dermatological diseases and disorders, reproductive diseases and disorders, urological diseases and disorders, allergies, bone diseases and disorders, diseases and disorders of the musculo-skeletal and genitourinary systems, and viruses and infectious diseases; therapeutic pharmaceutical for the treatment and prevention of cancer, cardiovascular diseases and disorders, respiratory diseases and disorders, gastrointestinal diseases and disorders, genetic and genomic diseases and disorders, immunological diseases and disorders, metabolic diseases and disorders, endocrine diseases and disorders, kidney diseases and disorders, dermatological diseases and disorders, reproductive diseases and disorders, urological diseases and disorders, allergies, bone diseases and disorders, diseases and disorders of the musculo-skeletal and genitourinary systems, and viruses and infectious diseases; pharmaceutical preparations, namely, DNA therapeutics for the treatment and prevention of cancer, cardiovascular diseases and disorders, respiratory diseases and disorders, gastrointestinal diseases and disorders, genetic and genomic diseases and disorders, immunological diseases and disorders, metabolic diseases and disorders, endocrine diseases and disorders, kidney diseases and disorders, dermatological diseases and disorders, reproductive diseases and disorders, urological diseases and disorders, allergies, bone diseases and disorders, diseases and disorders of the musculo-skeletal and genitourinary systems, and viruses and infectious diseases
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [001]
Chemical Products
Biological and chemical agents for scientific and research use
First Use Date in General
N/A
First Use Date in Commerce
N/A
Mark Details
Serial Number
No 98638645
Mark Type
No Service Mark
Attorney Docket Number
No F09472000000
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 02th Jan 2025 | NON-FINAL ACTION WRITTEN |
| 02th Jan 2025 | NON-FINAL ACTION E-MAILED |
| 02th Jan 2025 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| 30th Dec 2024 | ASSIGNED TO EXAMINER |
| 29th Aug 2024 | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP |
| 09th Jul 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| 09th Jul 2024 | NEW APPLICATION ENTERED |